Featured Research

from universities, journals, and other organizations

Side Effects Of Cholesterol-lowering Drugs

Date:
May 24, 2005
Source:
American Heart Association
Summary:
In a report published in the online issue of Circulation: Journal of the American Heart Association, (May 24, 2005), researchers said the cholesterol-lowering drug rosuvastatin (Crestor) was more likely to be associated with muscle damage (myopathy) compared to atorvastatin (Lipitor), simvastatin (Zorcor) and pravastatin (Pravachol).

In a report published in the online issue of Circulation: Journal of the American Heart Association, (May 24, 2005), researchers said the cholesterol-lowering drug rosuvastatin (Crestor) was more likely to be associated with muscle damage (myopathy) compared to atorvastatin (Lipitor), simvastatin (Zorcor) and pravastatin (Pravachol). Adverse events were rare and occurred in the first weeks of therapy. The side effects generally go away when the patient stops taking the drug.

Researchers analyzed post-marketing data from the U.S. Food and Drug Administration (FDA) on cholesterol-lowering drugs known as statins. They measured the data by recording rates of adverse event reports (AERS) per million prescriptions. Data from the first year of rosuvastatin's marketing were compared with concurrent data from atorvastatin, simvastatin and pravastatin.

"Statins are among our best drugs for treating individuals who have elevated cholesterol," said Alice K. Jacobs, M.D., president of the American Heart Association. "The study should reassure the public that the drugs are safe. Overwhelmingly, the majority of individuals tolerate statins very well, and the absolute risk of side effects is low, including for rosuvastatin."

For patients, the American Heart Association recommends:

* Statins are one of the most effective drugs to reduce elevated low-density lipoprotein (LDL) or "bad" cholesterol, which is associated with increased risk of cardiovascular disease.

* The absolute risk of side effects from statins is low.

* No medication should be discontinued without consulting a physician. Be aware of potential side effects and risks that can develop while taking the drug or after stopping the drug, and discuss them with a physician.

* Report side effects to your doctor when they occur; do not wait for the next visit.

* Higher doses of statins may be associated with a greater risk of side effects. Side effects tend to be dose-related and may disappear after reducing the dosage or, if necessary, withdrawing the medication.

* Patients who are currently taking rosuvastatin or any other statin should continue to take their medication as prescribed and consult with their physician if you have any question about dosage or risk of side effects.

For physicians and other health care providers, the American Heart Association recommends:

* The dose of statins should not exceed the level required to achieve current goals of therapy.

* Be knowledgeable of the factors that may increase the risk of myopathy (muscle weakness).

* Consider using combinations of cholesterol-lowering drugs at lower doses for patients at increased risk for myopathy. * Report adverse events to the FDA, to optimize the post-marketing surveillance system.

* Select statins based on the degree of LDL-lowering required to achieve the patient's recommended goal, the potential for side effects, and the patient's preferences (e.g., compliance, costs, etc.)

* The risks of specific statins should be weighed for each patient. In general, physicians should prescribe the lowest dose of statin to bring a patient's cholesterol to target levels.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Side Effects Of Cholesterol-lowering Drugs." ScienceDaily. ScienceDaily, 24 May 2005. <www.sciencedaily.com/releases/2005/05/050524100438.htm>.
American Heart Association. (2005, May 24). Side Effects Of Cholesterol-lowering Drugs. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/05/050524100438.htm
American Heart Association. "Side Effects Of Cholesterol-lowering Drugs." ScienceDaily. www.sciencedaily.com/releases/2005/05/050524100438.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins